Skip to main content
. 2022 Jun 10;15:904935. doi: 10.3389/fnmol.2022.904935

TABLE 1.

Summary of BRSK2 mutant patients’ early development and evaluation results.

Subjects Our patient #Patients published
Gender Male 11/12, Male
Diagnosis of ASD Yes 10/12, 1/12 Borderline
Speech delay Yes 12/12
Motor delay Yes 11/12
Intelligence disability No 10/12
Age of walking (months) 18 12–20
Age of speaking (months) 25 18–24/non-verbal at evaluation
Comorbidity
 Feeding problem Yes 2/12
 Epilepsy No 3/12
 Sleep disorder No 3/12
Clinical evaluations
Age of first GMDS (months) 19.5
 Locomotor DQ 69
 Personal-social DQ 46
 Hearing-speech DQ 33
 Hand-eye coordination DQ 59
 Performance DQ 49
Age of WPPSI-IV (years, months) 4,6
 VCI 88
 VSI 100
 FRI 89
 WMI 76
 PSI 86
 FSIQ 81
Age of ADOS (months) 19.5
Social affect 11
Restricted and repetitive behavior 2
Total score 13 (ASD cut-off:11)

#Only 12 of 14 patients with detailed clinical data published in previous studies. GMDS, Griffiths Mental Development Scales. WPPSI-IV, Wechsler Preschool and Primary Scale of Intelligence-Fourth Edition. VCI, Verbal Comprehension Index; VSI, Visual Spatial Index; FRI, Fluid Reasoning Index; WMI, Working Memory Index; PSI, Processing Speed Index; FSIQ, Full Scale Intelligence Quotient. ADOS, Autism Diagnostic Observation Schedule, second edition.